Recruiting NA INTERVENTIONAL 2-arm NCT06217939

Early Intravenous Hydrocortisone in Sepsis (EARL-HYDRO)

Early Intravenous Hydrocortisone in Sepsis: a Randomized Control Trial

Sponsor: Siriraj Hospital

Interventions Early hydrocortisone Normal saline placebo Open-label hydrocortisone

Updated 6 times since 2024 Last updated: Jan 5, 2026 Started: Jun 25, 2024 Primary completion: Jun 30, 2026 Completion: Sep 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Sepsis Severe and Shock, Septic, this trial is actively recruiting participants. The trial is conducted by Siriraj Hospital and has accumulated 6 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Recruiting NA
Aug 2025 — Feb 2026 [monthly]

Recruiting NA
Sep 2024 — Aug 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Feb 2024 — May 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Siriraj Hospital

Data source: Siriraj Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkoknoi, Thailand